Work

Nanotechnology-based drug delivery for central nervous system disorders

Year: 2021
Type: review
Abstract: Drug delivery to central nervous system (CNS) diseases is very challenging since the presence of the innate blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier that impede drug delivery. Among new strategies to overcome these limitations and successfully deliver drugs to the CNS, nanotechnology-based drug delivery platform, offers potential therapeutic approach for the treatment of some common neurological disorders like Alzheimer's disease, frontotemporal dementia, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease. This review aimed to highlight advances in research on the development of nano-based therapeutics for their implications in therapy of CNS disorders. The challenges during clinical translation of nanomedicine from bench to bed side is also discussed.
Language: English
Subfield: Biomaterials
Open Access status: gold
Estimated APC paid: $2,660
OpenAlex ID: W3197875435
FWCI: 1.763
Cites: 161
Cited by: 193
Related to: 10